Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female Participants
Completed · Phase 1
Conditions studied: Pain
In brief
The purpose of this study is to evaluate the effect of SUZ on the pharmacokinetics of oral contraceptives.
Key facts
- Study ID
- NCT06820307
- Run by
- Vertex Pharmaceuticals Incorporated
- People needed
- 50
- Starts
- 2025-02-25
- Expected to finish
- 2025-04-29
- Last updated by the study team
- 2025-05-29
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.
Where it is running
- Celerion - Tempe — Tempe, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.